The DOI matches its Crossref record; the references it cites are not checked yet.
Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction
Abstract
The reversible nature of early type 2 diabetes has been demonstrated in in vivo human studies. Recent in vivo and in vitro studies of β-cell biology have established that the β-cell loses differentiated characteristics, including glucose-mediated insulin secretion, under metabolic stress. Critically, the β-cell dedifferentiation produced by long-term excess nutrient supply is reversible. Weight loss in humans permits restoration of first-phase insulin secretion associated with the return to normal of the elevated intrapancreatic triglyceride content. However, in type 2 diabetes of duration greater than 10 years, the cellular changes appear to pass a point of no return. This review summarizes the evidence that early type 2 diabetes can be regarded as a reversible β-cell response to chronic positive calorie balance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, this option comes at a high financial cost and with the risk of long-term problems, such as post-prandial hypoglycaemia, and micronutrient deficiencies that restrict acceptability.25,26”
From Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial (2018) · cites this paper as [26]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 79 · Cited by 174
Research works printed but not linked: 1
- Himsworth, 1949, Diet in the aetiology of human diabetes, Proc R Soc Med, 42, 323
Metadata
- Authors
- White, M. G., Shaw, J. A. M., & Taylor, R.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Taylor, Roy
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-10-11
- Volume
- 39
- Issue
- 11
- Pages
- 2080-2088
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2535658226
- Cited by
- 174
- References
- 79
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 17 · 2023: 15 · 2022: 24 · 2021: 28 · 2020: 19 · 2019: 19 · 2018: 13 · 2017: 15 · 2016: 2
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council (MR/L022699/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 2 diabetes, beta-cell dysfunction, beta-cell dedifferentiation, first-phase insulin secretion, weight loss, metabolic stress, insulin secretion
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Cell Differentiation, Diabetes Mellitus, Type 2, Disease Models, Animal, Humans, Insulin, Disease Progression, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction. https://app.cochat.ai/papers/10.2337/dc16-0619
- The paper
- White, M. G., Shaw, J. A. M., & Taylor, R. (2016). Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction. Diabetes Care. https://doi.org/10.2337/dc16-0619
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.